These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 29290958)
1. Stromal Annexin A2 expression is predictive of decreased survival in pancreatic cancer. Murphy AG; Foley K; Rucki AA; Xia T; Jaffee EM; Huang CY; Zheng L Oncotarget; 2017 Dec; 8(63):106405-106414. PubMed ID: 29290958 [TBL] [Abstract][Full Text] [Related]
2. Semaphorin 3D autocrine signaling mediates the metastatic role of annexin A2 in pancreatic cancer. Foley K; Rucki AA; Xiao Q; Zhou D; Leubner A; Mo G; Kleponis J; Wu AA; Sharma R; Jiang Q; Anders RA; Iacobuzio-Donahue CA; Hajjar KA; Maitra A; Jaffee EM; Zheng L Sci Signal; 2015 Aug; 8(388):ra77. PubMed ID: 26243191 [TBL] [Abstract][Full Text] [Related]
3. Tyrosine 23 phosphorylation-dependent cell-surface localization of annexin A2 is required for invasion and metastases of pancreatic cancer. Zheng L; Foley K; Huang L; Leubner A; Mo G; Olino K; Edil BH; Mizuma M; Sharma R; Le DT; Anders RA; Illei PB; Van Eyk JE; Maitra A; Laheru D; Jaffee EM PLoS One; 2011 Apr; 6(4):e19390. PubMed ID: 21572519 [TBL] [Abstract][Full Text] [Related]
4. High Co-expression of Large Tenascin C Splice Variants in Stromal Tissue and Annexin A2 in Cancer Cell Membranes is Associated with Poor Prognosis in Pancreatic Cancer. Hagiwara K; Harimoto N; Yokobori T; Muranushi R; Hoshino K; Gantumur D; Yamanaka T; Ishii N; Tsukagoshi M; Igarashi T; Tanaka H; Watanabe A; Kubo N; Araki K; Hosouchi Y; Shirabe K Ann Surg Oncol; 2020 Mar; 27(3):924-930. PubMed ID: 31463696 [TBL] [Abstract][Full Text] [Related]
5. Hedgehog signaling stimulates Tenascin C to promote invasion of pancreatic ductal adenocarcinoma cells through Annexin A2. Foley K; Muth S; Jaffee E; Zheng L Cell Adh Migr; 2017 Sep; 11(5-6):514-523. PubMed ID: 28152318 [TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of annexin A2 and annexin A4 expression in patients with cervical cancer. Choi CH; Chung JY; Chung EJ; Sears JD; Lee JW; Bae DS; Hewitt SM BMC Cancer; 2016 Jul; 16():448. PubMed ID: 27402115 [TBL] [Abstract][Full Text] [Related]
7. Annexin A2 and S100A10 are independent predictors of serous ovarian cancer outcome. Lokman NA; Pyragius CE; Ruszkiewicz A; Oehler MK; Ricciardelli C Transl Res; 2016 May; 171():83-95.e1-2. PubMed ID: 26925708 [TBL] [Abstract][Full Text] [Related]
8. Relationship Between Circulating Tumor Cells and Annexin A2 in Early Breast Cancer Patients. Bystricky B; Cierna Z; Sieberova G; Janega P; Karaba M; Minarik G; Benca J; Sedlackova T; Jurisova S; Gronesova P; Pindak D; Macuch J; Mardiak J; Mego M Anticancer Res; 2017 May; 37(5):2727-2734. PubMed ID: 28476852 [TBL] [Abstract][Full Text] [Related]
9. Annexin A2 in renal cell carcinoma: expression, function, and prognostic significance. Yang SF; Hsu HL; Chao TK; Hsiao CJ; Lin YF; Cheng CW Urol Oncol; 2015 Jan; 33(1):22.e11-22.e21. PubMed ID: 25284003 [TBL] [Abstract][Full Text] [Related]
10. Prognostic and diagnostic significance of annexin A2 in colorectal cancer. Yang T; Peng H; Wang J; Yang J; Nice EC; Xie K; Huang C Colorectal Dis; 2013 Jul; 15(7):e373-81. PubMed ID: 23489866 [TBL] [Abstract][Full Text] [Related]
11. Circulating annexin A2 as a biomarker in gastric cancer patients: correlation with clinical variables. Tas F; Tilgen Yasasever C; Karabulut S; Tastekin D; Duranyildiz D Biomed Pharmacother; 2015 Feb; 69():237-41. PubMed ID: 25661364 [TBL] [Abstract][Full Text] [Related]
12. Clinical Significance of Annexin A2 Expression in Breast Cancer Patients. Gibbs LD; Mansheim K; Maji S; Nandy R; Lewis CM; Vishwanatha JK; Chaudhary P Cancers (Basel); 2020 Dec; 13(1):. PubMed ID: 33374917 [TBL] [Abstract][Full Text] [Related]
13. Annexin-A2 as predictor biomarker of recurrent disease in endometrial cancer. Alonso-Alconada L; Santacana M; Garcia-Sanz P; Muinelo-Romay L; Colas E; Mirantes C; Monge M; Cueva J; Oliva E; Soslow RA; Lopez MA; Palacios J; Prat J; Valls J; Krakstad C; Salvesen H; Gil-Moreno A; Lopez-Lopez R; Dolcet X; Moreno-Bueno G; Reventos J; Matias-Guiu X; Abal M Int J Cancer; 2015 Apr; 136(8):1863-73. PubMed ID: 25219463 [TBL] [Abstract][Full Text] [Related]
14. Pseudogenes of annexin A2, novel prognosis biomarkers for diffuse gliomas. Li S; Zou H; Shao YY; Mei Y; Cheng Y; Hu DL; Tan ZR; Zhou HH Oncotarget; 2017 Dec; 8(63):106962-106975. PubMed ID: 29291003 [TBL] [Abstract][Full Text] [Related]
15. Up-regulation of annexin A2 expression predicates advanced clinicopathological features and poor prognosis in hepatocellular carcinoma. Zhang H; Yao M; Wu W; Qiu L; Sai W; Yang J; Zheng W; Huang J; Yao D Tumour Biol; 2015 Dec; 36(12):9373-83. PubMed ID: 26109000 [TBL] [Abstract][Full Text] [Related]
16. Anxa2 binds to STAT3 and promotes epithelial to mesenchymal transition in breast cancer cells. Wang T; Yuan J; Zhang J; Tian R; Ji W; Zhou Y; Yang Y; Song W; Zhang F; Niu R Oncotarget; 2015 Oct; 6(31):30975-92. PubMed ID: 26307676 [TBL] [Abstract][Full Text] [Related]
17. Down-regulation of annexin II in prostate cancer is associated with Gleason score, recurrence, metastasis and poor prognosis. Ding T; Yang L; Wang Y; Yuan J; Chen T; Cai X Mol Med Rep; 2010; 3(5):781-7. PubMed ID: 21472314 [TBL] [Abstract][Full Text] [Related]
18. Circulating annexin A2 as a biomarker in patients with pancreatic cancer. Karabulut M; Afsar CU; Serilmez M; Karabulut S J Cancer Res Ther; 2020 Dec; 16(Supplement):S110-S115. PubMed ID: 33380663 [TBL] [Abstract][Full Text] [Related]
19. Annexin A2 is implicated in multi-drug-resistance in gastric cancer through p38MAPK and AKT pathway. Zhang ZD; Li Y; Fan Q; Zhao B; Tan B; Zhao XF Neoplasma; 2014; 61(6):627-37. PubMed ID: 25150310 [TBL] [Abstract][Full Text] [Related]
20. Immune features of the peritumoral stroma in pancreatic ductal adenocarcinoma. Ahmed A; Klotz R; Köhler S; Giese N; Hackert T; Springfeld C; Jäger D; Halama N Front Immunol; 2022; 13():947407. PubMed ID: 36131941 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]